Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Current Leases (2022 - 2026)

TransMedics has reported Current Leases over the past 4 years, most recently at $3.3 million for Q4 2025.

  • For Q4 2025, Current Leases rose 21.38% year-over-year to $3.3 million; the TTM value through Dec 2025 reached $3.3 million, up 21.38%, while the annual FY2025 figure was $3.3 million, 21.38% up from the prior year.
  • Current Leases for Q4 2025 was $3.3 million at TransMedics, up from $3.2 million in the prior quarter.
  • Over five years, Current Leases peaked at $3.3 million in Q4 2025 and troughed at $1.3 million in Q1 2022.
  • A 4-year average of $2.2 million and a median of $2.1 million in 2023 define the central range for Current Leases.
  • Biggest five-year swings in Current Leases: rose 10.77% in 2023 and later soared 41.23% in 2025.
  • Year by year, Current Leases stood at $1.4 million in 2022, then surged by 40.93% to $2.0 million in 2023, then surged by 34.0% to $2.7 million in 2024, then increased by 21.38% to $3.3 million in 2025.
  • Business Quant data shows Current Leases for TMDX at $3.3 million in Q4 2025, $3.2 million in Q3 2025, and $3.0 million in Q2 2025.